Ledger.Open graph →
SEC Form D · filed July 18, 2025

Ikena Oncology, Inc

Offering
$75.0M
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Richard Wooster · Boston, MADirectorOwen Hughes · Cambridge, MADirectorOtello Stampacchia · Boston, MADirectorJotin Marango · Boston, MAExecJean-Francois Formela · Broomfield, CODirectorMark Manfredi · Boston, MAExec · DirectorJeffrey Ecsedy · Boston, MAExecOwen Hughes · Cambridge, MADirectorIain Dukes · New York, NYDirectorMaria Koehler · Boston, MADirectorDavid Bonita · Montreal, Quebec, CanadaDirectorRichard Wooster · Boston, MADirectorOtello Stampacchia · Boston, MADirectorJotin Marango · Boston, MAExecJean-Francois Formela · Cambridge, MADirectorMark Manfredi · Boston, MAExec · DirectorJeffrey Ecsedy · Boston, MAExecOwen Hughes · Sudbury, MADirectorIain Dukes · New York, NYDirectorMaria Koehler · Boston, MADirectorDavid Bonita · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗